Health Catalyst Inc
$ 1.84
0.00%
13 Feb - close price
- Market Cap 130,145,000 USD
- Current Price $ 1.84
- High / Low $ 1.91 / 1.80
- Stock P/E N/A
- Book Value 4.70
- EPS -1.58
- Next Earning Report 2026-02-25
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.05 %
- ROE -0.31 %
- 52 Week High 5.56
- 52 Week Low 1.80
About
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah.
Analyst Target Price
$3.88
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-11 | 2025-08-07 | 2025-05-07 | 2025-02-20 | 2024-11-06 | 2024-08-07 | 2024-05-09 | 2024-02-22 | 2023-10-27 | 2023-08-08 | 2023-05-09 | 2023-02-28 |
| Reported EPS | 0.06 | -0.59 | 0.01 | 0.04 | 0.07 | 0.12 | 0.05 | 0.02 | 0.03 | 0.05 | 0.05 | -0.05 |
| Estimated EPS | 0.0629 | 0.04 | 0.03 | 0.0764 | 0.1 | 0.08 | 0.03 | -0.0002 | -0.02 | -0.02 | -0.04 | -0.11 |
| Surprise | -0.0029 | -0.63 | -0.02 | -0.0364 | -0.03 | 0.04 | 0.02 | 0.0202 | 0.05 | 0.07 | 0.09 | 0.06 |
| Surprise Percentage | -4.6105% | -1575% | -66.6667% | -47.644% | -30% | 50% | 66.6667% | 10100% | 250% | 350% | 225% | 54.5455% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-25 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.0 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: HCAT
2026-02-13 10:28:09
Health Catalyst, Inc. (NASDAQ:HCAT) has a low price-to-sales (P/S) ratio of 0.4x, which is significantly lower than the Healthcare Services industry average. This low P/S ratio is attributed to the company's sluggish revenue growth, with analysts forecasting a decline of 0.2% per annum over the next three years, contrasting sharply with the industry's projected 13% annual growth. The article suggests that improved revenues are necessary for the company's shares to perform better.
2026-02-12 23:28:13
Health Catalyst (HCAT) and F5 (FFIV) stocks traded down following a broad market sell-off, driven by investor selectivity in the AI boom and dampened expectations for near-term interest rate cuts. A stronger-than-expected U.S. jobs report pushed back anticipated Fed rate cuts to July, negatively impacting growth-oriented sectors like software due to higher interest rates. Health Catalyst, in particular, saw its shares fall by 6.8% and is down 18.9% year-to-date, trading significantly below its 52-week high.
2026-02-12 15:28:09
Health Catalyst, Inc (HCAT) is a healthcare data and analytics company with a current stock price of $1.99 and a market capitalization of $140.75 million. Despite recent volatility and unprofitability, the stock is oversold with a positive free cash flow, and analysts project a potential upside of nearly 95% to a consensus target price of $3.88. The company's Ignite platform and expertise solutions position it to capitalize on demand for data-driven healthcare solutions, making it an intriguing option for growth-seeking investors.
2026-02-09 19:59:26
Health Catalyst emphasizes that AI-driven, near-real-time data analytics are crucial for improving clinical outcomes, moving beyond just raw data. Leaders from the company highlighted this approach in a recent video and article on Healthcare IT Today. This strategy aims to provide clinicians with actionable insights, thereby advancing patient care effectively.
2026-02-03 20:57:54
Shares of Health Catalyst (HCAT) fell by 8.4% due to investor fears regarding artificial intelligence disruption, leading to a broad-based sell-off in the healthcare data analytics sector. This "basket-style reaction" affected the S&P 500 Information Technology Sector and the Magnificent Seven stocks. The movement suggests that while the market sees the news as meaningful, it doesn't fundamentally alter its perception of Health Catalyst's business despite the stock's year-to-date decline and significant drop from its 52-week high.
2026-02-03 15:57:54
Health Catalyst helps healthcare organizations move beyond traditional analytics to drive actual clinical improvement by providing near-real-time data, using AI to prioritize effective interventions, and fostering clinician ownership of solutions. This approach enables faster feedback, targeted actions, and sustainable change, turning analytics into a tool that directly influences patient care outcomes. The company emphasizes that lasting improvements come from clinicians designing solutions they trust, supported by data that confirms their impact.
